British Prime Minister Boris Johnson received his first dose of the AstraZeneca COVID-19 vaccine on Friday and urged the public to do the same, saying "he did not feel a thing."
Johnson, 56, received his vaccine at the same hospital where almost a year ago he was put in an intensive care unit and given oxygen via a tube in his nose after he contracted the virus and fell seriously ill. He later said he was so sick that plans were drawn up on how to announce his death.
"I literally did not feel a thing. It was very good, very quick," Johnson said after receiving the injection at St Thomas' Hospital in London.
"I cannot recommend it too highly, everybody when you do get your notification to go for a jab, please go and get it, it is the best thing for you, best thing for your family and for everyone else."
Pictures showed the prime minister wearing a black mask, a shirt and tie with his sleeve rolled up while a nurse gives him the vaccine.
Britain broke its record for the most coronavirus shots given out in one day on Friday and almost half of all adults have received one dose, making it one of the fastest countries in the world to roll out a vaccine programme.
This success has helped the ruling Conservatives regain the lead over the main opposition Labour Party in opinion polls after the prime minister last year was accused of acting too slowly to stop the spread of the virus.
Johnson received his vaccine as European countries on Friday resumed using the AstraZeneca shot after regulators said its benefits outweighed any risks following recent reports of blood clots.
Countries including Germany and France reversed their decision to temporarily pause its use after reports of about 30 cases of rare brain blood clots sent scientists and governments scrambling to determine any link.
The AstraZeneca vaccine, developed by scientists at the University of Oxford, has also been at the centre of tensions between Britain and the European Union, after Brussels expressed anger over the lack of deliveries of the shot coming from Britain.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU